Implementation of the mouse frailty index.

Area of Science:

• Gerontology and Aging Research
• Preclinical Models in Medicine
• Biomedical Research

Background:

• Frailty signifies increased vulnerability to adverse health outcomes, higher mortality, and greater healthcare utilization.
• Despite its clinical significance, the underlying biology, impact on treatment outcomes, and interventions for frailty remain poorly understood.
• The human frailty index (FI), based on deficit accumulation, provides a quantitative measure.

Purpose of the Study:

• To review the current applications of the mouse frailty index (FI) in preclinical research.
• To assess factors influencing the reliability and implementation of the mouse FI.
• To identify future research directions for attenuating frailty using this model.

Main Methods:

• Literature review of existing studies utilizing the mouse FI.
• Presentation of original data related to mouse FI assessment.
• Analysis of inter-rater reliability and the impact of observer/environmental factors on mouse FI scores.

Main Results:

• The mouse FI is a validated preclinical tool applicable across various research areas.
• Factors such as observer characteristics and environmental conditions can influence mouse FI scores.
• Specific items contributing to the FI assessment require careful consideration for consistent scoring.

Conclusions:

• The mouse FI is a valuable tool for advancing translational research in frailty.
• Standardization of mouse FI assessment is crucial for reliable and reproducible results.
• Further research is needed to optimize the use of the mouse FI for developing interventions.